Skip to main content

Profiles

Bayer

Bayer is a German multinational pharmaceutical company based in Leverkusen, North Rhine-Westphalia.

History

Bayer closed a deal to acquire Monsanto in June 2018.[1][2]

COVID-19

On March 25, 2020, Bayer was announced as a partner of the COVID-19 Therapeutics Accelerator funded by the Bill & Melinda Gates Foundation, Wellcome Trust, and Mastercard to “accelerate treatments, vaccines, and diagnostics.”[3]

On May 26, 2020, Bayer received a $930,000 grant from the Government of Canada through the Global Innovation Clusters program for a project titled "Improving ICU Capacity During COVID-19 Outbreaks." Bayer's partners on the project included numerous hospitals in Toronto, Ontario.[4]

On June 6, 2023, Bayer announced it had partnered with Acuitas Therapeutics to "support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver."[5][6]

Organization

Name Position Notes
Amy Kelly Technical Documentation Specialist (Contractor)[7] DailyClout

Partners

Bayer is a partner of:

Bayer is a member of:

Bayer has received investment funding from the Bill & Melinda Gates Foundation Strategic Investment Fund.[18]

Subsidiaries

Activities

Bayer has provided funding to individuals engaged in the public health response to COVID-19.

Name Type Amount Description
Menaka Pai Speakers Bureau/Honoraria Unknown Disclosed during a June 2020 presentation to the Ontario Regional Blood Coordinating Network[20]

Bayer has also provided funding to numerous organizations:

  1. Kresge, N. (2018, June 7). Bayer Closes Monsanto Deal to Cap $63 Billion Transformation. Bloomberg. https://web.archive.org/web/20230830205801/https://www.bloomberg.com/news/articles/2018-06-07/bayer-closes-monsanto-deal-to-cap-63-billion-transformation#xj4y7vzkg ↩︎

  2. Poisoned By PCBs: “A Lack of Control.” (2009, March 27). Chemical Industry Archives; Environmental Working Group. https://web.archive.org/web/20151210110457/http://www.chemicalindustryarchives.org/dirtysecrets/anniston/2.asp ↩︎

  3. Life Science Companies Commit to the Fight Against COVID-19 Pandemic alongside Gates Foundation. (2020, March 25). Bill & Melinda Gates Foundation. https://web.archive.org/web/20231126155705/https://www.gatesfoundation.org/Ideas/Media-Center/Press-Releases/2020/03/Life-Science-Companies-Commit-to-the-Fight-Against-COVID-19-Pandemic-alongside-Gates-Foundation ↩︎

  4. Canada’s cluster projects: COVID-19 response. (2022, August 19). Innovation, Science and Economic Development Canada. https://web.archive.org/web/20230706210728/https://ised-isde.canada.ca/site/global-innovation-clusters/en/canadas-cluster-projects-covid-19-response ↩︎

  5. Nagle, C. (2023, June 6). Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics. Business Wire. https://web.archive.org/web/20230708013347/https://www.businesswire.com/news/home/20230606005983/en/Bayer-Strengthens-Gene-Therapy-Portfolio-With-Lipid-Nanoparticle-Technology-From-Acuitas-Therapeutics ↩︎

  6. Taylor, N. P. (2023, June 7). Bayer bags access to gene editing delivery tech from biotech behind Pfizer’s COVID-19 vaccine. Fierce Biotech. http://archive.today/2023.07.08-013704/https://www.fiercebiotech.com/biotech/bayer-bags-access-gene-editing-delivery-tech-biotech-behind-pfizers-covid-19-vaccine ↩︎

  7. Experience | Amy Kelly. LinkedIn. Retrieved January 7, 2024, from https://www.linkedin.com/in/amywkelly/details/experience/ ↩︎

  8. Pipeline. Dewpoint Therapeutics. Retrieved July 3, 2023, from http://archive.today/2023.07.03-184111/https://dewpointx.com/pipeline/%23partnerships ↩︎

  9. Bayer. World Economic Forum. Retrieved November 30, 2023, from https://web.archive.org/web/20231130213519/https://www.weforum.org/organizations/bayer-d57cbbcd2e/ ↩︎

  10. Member Logos. Ad Standards. Retrieved September 17, 2021, from https://web.archive.org/web/20210917052119/https://adstandards.ca/about/membership/member-logos/ ↩︎

  11. Members. AdvaMed. Retrieved July 13, 2014, from http://archive.today/2014.07.13-182356/http://advamed.org/page/33/members ↩︎

  12. Members & Profiles. Alliance for Regenerative Medicine. Retrieved October 5, 2022, from http://archive.today/2022.10.05-211734/https://alliancerm.org/members/members-and-profiles/ ↩︎

  13. COA Corporate Members. (2023, October 23). AS/COA. http://archive.today/2023.08.22-171902/https://www.as-coa.org/about/coa-corporate-members ↩︎

  14. Member Listings. BIOTECanada. Retrieved June 18, 2022, from http://archive.today/2022.06.18-172815/https://www.biotech.ca/about/member-listings/ ↩︎

  15. BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory ↩︎

  16. Member Companies. Innovative Medicines Canada. Retrieved April 14, 2021, from https://web.archive.org/web/20210414150341/http://innovativemedicines.ca/about/member-companies/ ↩︎

  17. About. PhRMA. Retrieved September 14, 2023, from https://web.archive.org/web/20230914221250/https://phrma.org/About ↩︎

  18. Portfolio - Page 1. Bill & Melinda Gates Foundation Strategic Innovation Fund. Retrieved December 24, 2023, from https://web.archive.org/web/20231224051809/https://sif.gatesfoundation.org/portfolio/?fwp_per_page=30 ↩︎

  19. Approach. Leaps by Bayer. Retrieved September 29, 2023, from https://web.archive.org/web/20230929225921/https://leaps.bayer.com/approach#about ↩︎

  20. Pai, M. (2020, June). Anemia and Heavy Menstrual Bleeding. Ontario Regional Blood Coordinating Network. https://web.archive.org/web/20240106183554/https://transfusionontario.org/wp-content/uploads/2020/06/Anemia-and-Heavy-Menstrual-Bleeding.pdf ↩︎

  21. Home. The ACT Foundation. Retrieved June 4, 2002, from http://archive.today/2002.06.04-050606/http://www.actfoundation.ca/main.html ↩︎

  22. Henderson, C. (2022, September). Annual Report 2021: The Big Step Up. American Diabetes Association. https://web.archive.org/web/20221019182708/https://diabetes.org/sites/default/files/2022-09/2021-ADAAnnualReport.pdf ↩︎

  23. Corporate Support. American Society of Hematology. Retrieved June 10, 2022, from http://archive.today/2022.06.10-180740/https://www.hematology.org/about/corporate-support ↩︎

  24. Our Sponsors and Prizes. BC Pharmacy Association. Retrieved May 22, 2022, from http://archive.today/2022.05.23-043337/https://www.bcpharmacy.ca/conference/prizes/2022 ↩︎

  25. Final Release Package A-2023-00059 CBC, Advertising Companies. CBC/Radio-Canada. Retrieved October 1, 2023, from https://archive.org/details/final-release-package-a-2023-00059-cbc-advertising-companies ↩︎

  26. 2015/2016 Annual Report. Canadian Lung Association. Retrieved March 2, 2023, from https://web.archive.org/web/20230202064219/https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2015_2016_EN.pdf ↩︎

  27. Our Partners. CSN/SCN. Retrieved January 8, 2022, from http://archive.today/2022.01.08-161403/https://www.csnscn.ca/our-partners/ ↩︎

  28. Partners. CanVECTOR. Retrieved January 10, 2022, from http://archive.today/2022.01.10-230557/https://www.canvector.ca/about/partners ↩︎

  29. Funding Partners. Can-SOLVE CKD Network. Retrieved January 8, 2022, from https://web.archive.org/web/20220108183212/https://cansolveckd.ca/about/funding-partners/ ↩︎

  30. Block, T. M., & Rosen, J. 2014 Annual Report. Hepatitis B Foundation. Retrieved July 12, 2019, from https://web.archive.org/web/20190712135553/http://www.hepb.org/assets/PDFs/2014-Hep-B-Foundation-Annual-Report.pdf ↩︎

  31. Plump, A., & Miller, A. M. (2022, June). 2021 Annual Report. PhRMA Foundation. https://web.archive.org/web/20230219205032/https://www.phrmafoundation.org/wp-content/uploads/2022/06/PhRMAFoundation_2021AnnualReport.pdf ↩︎

  32. Support Our Partners. Prostate Cancer Foundation. Retrieved November 4, 2023, from https://web.archive.org/web/20231104160052/https://www.pcf.org/about-us/partners/ ↩︎

  33. Voluntary contributions by fund and by contributor, 2021. (2022). World Health Organization. https://web.archive.org/web/20220516042059/https://apps.who.int/gb/ebwha/pdf_files/WHA75/A75_INF5-en.pdf ↩︎